MISTIE INTRACEREBRAL HEMORRHAGE TRIAL

Does faster clot removal in ICH give better patient outcomes?

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form
17

Please save the date for our

Quarterly MISTIE III Safety Forum

To be held via webinar

Wednesday, September 16th, 1-2pm EDT

 

Registration link: https://attendee.gotowebinar.com/register/4448979556126173697

 

Agenda to follow.

14

Our next MISTIE III Quarterly Refresher will be held via webinar

on Thursday, August 13, 10am - 2pm Eastern time.

 

You must register at: https://attendee.gotowebinar.com/rt/4351198883661957633

Once registered, details of the webinar will be e-mailed to you.

 

Please contact your Site Manager with any questions!

 

80

We missed Nicki at our MISTIE team meeting this week, but it seems she had a good excuse! She is now a proud new grandmother of a beautiful 5.4 pound little girl named Lili who was born on July 8th.  Congratulations Nicki!

233

Click here to view a recording of the June 10th Safety Forum.

 

Please save the date for our

First Quarterly MISTIE III Safety Forum

 

To be held via webinar

Wednesday, June 10th, 1-2pm EDT

 

Agenda

·       Equipoise in MISTIE III - Andrew Carlson, MD, University of New Mexico

·       Quarter-Mile Marker: Where Do We Stand Surgically? - Surgical Center Leadership

·       Heparin Use in MISTIE III – Safety Committee

 

Please RSVP to your Site Manager and register here:

https://attendee.gotowebinar.com/register/537770843890118937

 

Once registered, webinar details will be e-mailed to you.  All are welcome to attend.

500

The 500th and final patient in the CLEAR-III trial was randomized on 14-Jan-2015, closing the enrollment period for this trial. Sites have until the end of January to enter any remaining screens. The trial continues in follow-up with the last patient's last visit (LPLV) expected in February 2016. 

Brain Injury Outcomes

Johns Hopkins University
1550 Orleans Street
CRB-II, 3M50 South
Baltimore, MD 21231 USA
Office:   (410) 614-6996
Fax: (410) 502-7869
 
24-Hr: (410) 736-1368